share_log

Exopharm Ltd: Appendix 4D and Half Year Report for period 31 December 2023

Feb 26 17:03
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more